Conjunctivitis, Bacterial: Clinical Trials

2 trials for Conjunctivitis, Bacterial, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 withdrawn. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Withdrawn 2
Phase 21Withdrawn 1

Follow Conjunctivitis, Bacterial: new trials by email Literature Review of Conjunctivitis, Bacterial trials Research Report on Conjunctivitis, Bacterial

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nepal Elimination of Trachoma Study
Azithromycin - Trachoma
Phase 2 / Phase 3WithdrawnUniversity of California, San Francisco2014-08-012015-05-21
Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection
azithromycin 1.5%/Loteprednol 0,5% + placebo, azithromycin 1.5% + Loteprednol 0,5% (separately) - Ocular Inflammation, Infection Associated Blepharitis
Phase 3WithdrawnAdapt Produtos Oftalmológicos Ltda.2012-12-012014-12-11

Narrower conditions

Blepharitis (1)  ·  Conjunctivitis (1)  ·  Keratitis (1)  ·  Trachoma (1)

Broader conditions

Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Conjunctival Diseases (2)  ·  Corneal Diseases (2)  ·  Eye Diseases (2)  ·  Eye Infections (2)  ·  Eye Infections, Bacterial (2)  ·  Infections (2)  ·  Chlamydia Infections (1)  ·  Chlamydiaceae Infections (1)  ·  Conjunctivitis (1)  ·  Eyelid Diseases (1)  ·  Gram-Negative Bacterial Infections (1)

Interventions

Azithromycin (2)

Sponsors

Adapt Produtos Oftalmológicos Ltda. (1)  ·  University of California, San Francisco (1)

Countries

Brazil (1)  ·  Nepal (1)

Top investigators

Bruce D Gaynor, MD (1)  ·  Rubens Belfort Jr., MD (1)

NIH funding

K23EY019881 (1)